Pretty instantly? Sure shorters would have time to do what they...

Pretty instantly? Sure shorters would have time to do what they want, not much to be done unless there is clear guidance as to what is happening at the time of any stop go announcement. It would be a bit hard for Mesoblast to apply for an EUA with nil data.

But how would the 2 members of the Public Health Emergency Medical Countermeasures Enterprise with greatest clarity on what is happening after the DSMB analysis view a product that, in either of the scenarios, seems to be performing better than SOC. Surely they would want it out there and available ASAP, not weeks or months later. The COVID-19 daily death rate in the US indicates there is an unfulfilled need, the FDA and NIH have fairly direct responsibilities in that respect as members of the PHEMCE.